Proteon Therapeutics Inc (PRTO): Flynn’s Purchasing RaceBy Jodor JalitOctober 28, 2014 James E. Flynn, a large shareholder at Proteon Therapeutics Inc (NASDAQ:PRTO) disclosed today the acquisition of 1,255,107 shares of common…
BioTech Ra Capital Management Considerably Surges Stake in Dyax Corp. (DYAX)By Casey SandersMay 5, 2014 Peter Kolchinsky’s Ra Capital Management considerably boosted its stake in Dyax Corp. (NASDAQ:DYAX), a recent 13G filing with the SEC shows. The…